Providence Wealth Advisors, LLC Abb Vie Inc. Transaction History

Providence Wealth Advisors, LLC

$116 Million
Q1 2024

A detailed history of Providence Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Providence Wealth Advisors, LLC holds 13,166 shares of ABBV stock, worth $2.26 Million. This represents 2.07% of its overall portfolio holdings.

Number of Shares

13,166

Previous 12,954 1.64%

Holding current value

$2.26 Million

Previous $1.93 Million 24.2%

% of portfolio

2.07%

Previous 2.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $33,881 - $38,605	212 Added 1.64%	13,166 $2.4 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $54,638 - $63,251	-409 Reduced 3.06%	12,954 $1.93 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $79,108 - $98,445	-597 Reduced 4.28%	13,363 $1.8 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $58,856 - $67,781	-407 Reduced 2.83%	13,960 $2.22 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $24,480 - $29,358	177 Added 1.25%	14,367 $2.32 Million

Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $81,733 - $93,743	609 Added 4.48%	14,190 $2.13 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $136,519 - $173,560	992 Added 7.88%	13,581 $2.06 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $123,665 - $153,433	-937 Reduced 6.93%	12,589 $2.05 Million
Q4 2021 Jan 12, 2022	BUY	$107.43 - $135.93 $215,826 - $273,083	2,009 Added 17.44%	13,526 $1.83 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $119,912 - $136,119	-1,127 Reduced 8.91%	11,517 $1.25 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $14,098 - $15,706	134 Added 1.07%	12,644 $1.46 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $98,514 - $108,453	963 Added 8.34%	12,510 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $97,714 - $131,925	1,214 Added 11.75%	11,547 $1.22 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $397,591 - $466,641	4,628 Added 81.12%	10,333 $905,000
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $150,701 - $201,661	2,054 Added 56.26%	5,705 $560,000
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $8,643 - $13,103	134 Added 3.81%	3,651 $265,000
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $577 - $722	8 Added 0.23%	3,517 $311,000
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $220,996 - $265,701	3,509 New	3,509 $266,000
Q2 2019 Jul 22, 2019	SELL	$65.7 - $83.98 $215,298 - $275,202	-3,277 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$77.14 - $90.79 $462 - $544	6 Added 0.18%	3,277 $263,000
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $22,965 - $28,322	-295 Reduced 8.27%	3,271 $298,000
Q3 2018 Nov 01, 2018	BUY	$88.91 - $98.84 $444 - $494	5 Added 0.14%	3,566 $337,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $22,893 - $27,088	255 Added 7.71%	3,561 $330,000
Q1 2018 Aug 14, 2018	BUY	$92.01 - $123.21 $304,185 - $407,332	3,306 New	3,306 $302,000

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Wealth Advisors, LLC with notifications on news.

Account

Providence Wealth Advisors, LLC Abb Vie Inc. Transaction History